A carregar...
Paronychia and Periungual Granulation as a Novel Side Effect of Ibrutinib: A Case Report
Ibrutinib is an oral covalent inhibitor of the Bruton's tyrosine kinase pathway and is approved for the treatment of B-cell malignancies including chronic lymphocytic leukaemia, mantle cell lymphoma, and Waldenström's macroglobulinaemia. It is generally a drug of choice for high-risk patie...
Na minha lista:
| Publicado no: | Skin Appendage Disord |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6995981/ https://ncbi.nlm.nih.gov/pubmed/32021859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502986 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|